Kevin Kuykendall, CEO of Vivione Biosciences, Discusses Startup Companies (Exec Q&A)

by Mark Carter  on Monday, May. 7, 2012 12:00 am  

Kevin Kuykendall, CEO of Vivione Biosciences

Kevin Kuykendall is the new chief executive at Vivione Biosciences, a Little Rock startup formerly known as Litmus Rapid-B.

Want the Full Article?

Get Unlimited Archive Access for $19.95 per Year

Readers must pay to access stories older than 20 days.

Purchase Now

Already have archive access? Login to view this article.

Search

Latest Arkansas Business Poll

Is the new religious objections law a good compromise?